John Maki of Vicus Therapeutics
joined us for World Orphan Drug Congress USA 2015 to present about '
Bringing Next Generation Immunotherapy to Cancer'
Download the presentation now to learn more about:
Vicus' next generation targets
First multi-pathway neuro-immune modulator for cancer
VT-122 pipeline in a product (today)
VT-122 pipeline in a product (2018)
Get your copy here!
To find out more about
Vicus Therapeutics' next generation immunotherapy
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (5,169Kb in size)